Indian startup Mylab to develop molecular diagnostics in UAE and Kuwait

Mylab Discovery Solutions, a leading biotech company in India, has announced an exclusive strategic partnership with AstraGene LLC, UAE’s first Molecular Diagnostics Manufacturing company, for developing automated molecular diagnostics for the UAE and Kuwait markets.

Under the agreement, Mylab and AstraGene will co-develop molecular diagnostic solutions including reagents and kits as well as fully-automated devices. This partnership marks Mylab’s latest international market expansion and supports the company's long-term growth strategy to make high quality diagnostics more accessible around the world.

This partnership will play an essential role in upgrading laboratory infrastructure in the UAE and Kuwait, and will support the installation of advanced diagnostic systems in the laboratories.

Together, the companies will develop world-class molecular diagnostic solutions to support the UAE and Kuwait healthcare sectors and make innovative tests available to patients.

Speaking on the partnership, Hasmukh Rawal, MD of Mylab said, “This partnership is a step towards expanding our presence in the fast-growing molecular diagnostics markets. Our comprehensive product portfolio of molecular diagnostic kits along with AstraGene’s local expertise in this space, will enable laboratories in the UAE & Kuwait to drive better outcomes and provide enhanced diagnosis to the patients. We will continue to expand our geographic footprint to other regions through similar partnerships.”